China's Ascendance in Global Healthcare: A New Era for Medical Tourism

The reception area at Beijing United Family Hospital, as observed by Global Times reporters, presents a striking image of an international hub, with bilingual signs in English and Chinese prominently displayed. In its corridors, foreign patients engage fluently with medical professionals in English, while nurses offer warm greetings, creating an atmosphere reminiscent of a vibrant international community rather than a typical, often crowded, medical facility. This setting underscores a significant shift in the global landscape of medical tourism, with China increasingly emerging as a premier healthcare destination.

On the morning of March 25, 2026, a reporter encountered Alex (a pseudonym), a 45-year-old patient battling multiple myeloma, in his hospital room. Days before his scheduled discharge, Alex articulated his profound satisfaction with the care received, clutching two pages of handwritten notes to ensure he conveyed every detail of his experience.

"It's very good, very excellent high-quality care I received. I was very impressed," Alex shared with the Global Times.

His comprehensive three-month treatment concluded on March 28, after which he departed for his home country. As a parting gesture, his medical team presented him with several refrigerator magnets, each depicting iconic Chinese symbols such as the Temple of Heaven, an ancient Chinese phoenix crown, and the famous Si Yang Fang Zun (Four-Goat Square Zun), a bronze vessel from the Shang Dynasty (C.1600BC-1046BC). These mementos, each accompanied by an English label explaining its cultural significance, were offered by Chinese doctors speaking fluent English, with the hope that Alex and his family would fondly recall their medical journey in China upon seeing them. This blend of cutting-edge medical care and cultural immersion exemplifies China's growing appeal as a holistic healthcare destination.

Alex's remarkable journey, from a desperate international search for treatment to regaining his health and receiving these thoughtful souvenirs, illustrates the burgeoning global recognition of Chinese medical innovation and the quality of care available. In line with the nation's ambitious Healthy China Initiative and the strategic objectives of the 15th Five-Year Plan period (2026-2030), foreign-funded hospitals in China, with their inherent international operational models and patient-centric philosophies, are playing a pivotal role. They serve as essential conduits, connecting international patients with China's advanced medical resources and solidifying its position in cross-border healthcare.

Navigating Global Healthcare: Building Trust Across Borders

Alex (right) receives farewell gifts from staff members at Beijing United Family Hospital on March 25, 2026. Photo: Lin Xiaoyi/GT

Alex's decision to seek treatment in China stemmed from an exhaustive global quest for viable options. Diagnosed with multiple myeloma in April 2022, a rare and frequently relapsing blood cancer, he had undergone numerous rounds of chemotherapy and targeted therapies in his home country over three years. Despite achieving clinical remission twice, the cancer recurred in November 2025, at which point his local physicians informed him that further effective treatment avenues were exhausted. This dire situation forced him to explore international patient care options.

Unyielding in his pursuit of health, Alex researched global alternatives, discovering that chimeric antigen receptor (CAR) T-cell therapy represented one of the most effective treatments for relapsed and refractory multiple myeloma. While this innovative therapy was not yet commercially accessible in his own nation, and despite its maturity in the US, it came with prohibitive waiting lists. The complexities of patient travel and accessing specialized treatments highlight the growing need for efficient global healthcare pathways.

A pivotal referral ultimately redirected his path. Guided by his local doctor, Alex established contact with the hematology team at United Family in Beijing. "We learned that the development of CAR-T therapy in China has been very rapid. It has been in clinical application since 2017, with a large number of cases," Alex stated. However, his initial optimism was tempered by practical concerns: overcoming language barriers for medical communication, adapting to unfamiliar cuisine, and securing a medical visa. These anxieties, common for international patients, represented significant obstacles to accessing medical care in China.

These perceived barriers were systematically dismantled by the hospital's dedicated international team, who engaged in approximately 60 email exchanges with Alex and his family over nearly three weeks. This extensive communication exemplifies the high level of international patient care provided.

"From remote multidisciplinary consultations and professional explanations of the treatment plan to practical arrangements for living in China and full assistance with the medical visa, those 60 e-mails built trust step by step," explained Liu Wei, general manager of United Family Healthcare Beijing-Tianjin Market, to the Global Times. This meticulous approach is crucial for establishing confidence in cross-border healthcare services.

The international team meticulously detailed the treatment plan and potential risks, even offering Alex's family a virtual tour of the hospital. Ji Yu, Alex's attending physician, elaborated, "Based on his complete medical history, we broke down the complex treatment plan step-by-step, using simple analogies and language he could understand." This personalized communication is a hallmark of quality of care in medical tourism.

Upon their arrival in Beijing on December 26, 2025, the hospital's staff provided comprehensive support, assisting with everything from obtaining a local SIM card and securing nearby accommodation to guiding them on food purchases and facilitating cross-border money transfers. Such thoughtful services are instrumental in easing the transition for patients undertaking medical travel and navigating life in a new country.

Alex candidly admitted, "Before coming to China, we knew almost nothing about Chinese hospitals. They don't do massive marketing like hospitals in Europe and America," describing his initial choice as a significant leap of faith. Yet, his experience of the entire treatment process led to enthusiastic praise: "The doctors and nurses here are not only highly professional but also exceptionally attentive and caring." This sentiment reflects a growing recognition of China as a viable health tourism destination.

China's Medical Value Proposition: A Blend of Technology, Efficiency, and Compassion

"Here, there is advanced treatment technology, an efficient process, considerate service and medical staff you can trust," Alex affirmed, expressing his strong intent to recommend Chinese healthcare to fellow patients and friends. This endorsement highlights the critical components that define a superior healthcare destination.

Liu Wei believes that Alex's successful recovery is a testament to China's remarkable technological advancements in CAR-T therapy, coupled with the distinctive strengths of foreign-invested private hospitals. These institutions adeptly integrate cutting-edge medicine with highly personalized international patient care.

"China and the US conduct the most CAR-T clinical trials globally, and China now surpasses the US in the number of trials. More and more innovative treatments are becoming available here," Liu Wei pointed out. This leadership in clinical research positions China as a formidable player in global healthcare innovation.

Treatment efficiency stands out as a significant advantage attracting international patients. Alex's personal experience confirmed this: in other countries, such specialized treatment might involve a waiting period of one or two years. In contrast, he received an immediate response upon contacting the doctors, and his treatment commenced very swiftly. This speed of access is a crucial differentiator for patients seeking timely interventions through medical tourism.

"This technological appeal needs an efficient, agile diagnostic system to support it, and China has clear advantages in response speed and process flexibility," explained Ji Yu. She noted that when collecting cells from Alex, whose blood vessels were severely compromised by prior chemotherapy, the medical team proactively sought solutions, ultimately placing a femoral venous catheter. Nurses provided constant vigilance to prevent side effects like low calcium, while private rooms and stringent infection control protocols offered vital protection for his immunocompromised state. This comprehensive approach underscores the quality of care provided.

Furthermore, information obtained by the Global Times from Beijing United Family Hospital indicates that CAR-T treatment in China is significantly more cost-effective than in Western countries, typically ranging from one-half to one-third the cost of comparable treatments in the US. This affordability is a compelling factor for many foreign patients choosing China for cross-border healthcare. Alex himself stated he would strongly encourage other patients to consider China for their treatment.

If technological prowess, operational efficiency, and economic viability represent the